Clinical trial
Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised…
NCT00134342 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00134342 |
|---|---|
| Title | Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations |
| Official title | A Comparison of Traditional Tuberculosis Screening Methods With the T-SPOT TB Test for the Diagnosis of Latent Tuberculosis Infection in Immunocompromised Populations |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Oxford Immunotec Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Tuberculosis |
| Intervention type | Other |
| Interventions | T-SPOT TB ELISPOT test |
| Enrollment | 203 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Aug 24, 2005 |
| Last update posted | Dec 23, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: